Sculptor Capital LP bought a new position in Cartica Acquisition Corp (NASDAQ:CITE – Get Rating) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 500,000 shares of the company's stock, valued at approximately $5,000,000. Sculptor Capital LP owned approximately 2.00% of Cartica Acquisition as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Lynwood Capital Management Inc. purchased a new stake in Cartica Acquisition in the 1st quarter worth approximately $132,000. Glazer Capital LLC bought a new position in shares of Cartica Acquisition during the 1st quarter valued at $191,000. OMERS ADMINISTRATION Corp bought a new position in shares of Cartica Acquisition during the 1st quarter valued at $200,000. Berkley W R Corp bought a new position in shares of Cartica Acquisition during the 1st quarter valued at $250,000. Finally, DLD Asset Management LP bought a new position in shares of Cartica Acquisition during the 1st quarter valued at $346,000. Hedge funds and other institutional investors own 67.29% of the company's stock.
Get Cartica Acquisition alerts:Cartica Acquisition Stock Performance
Cartica Acquisition stock opened at $10.10 on Friday. The firm's fifty day simple moving average is $10.06. Cartica Acquisition Corp has a 1-year low of $9.80 and a 1-year high of $10.14.
Cartica Acquisition Company Profile
(Get Rating)Cartica Acquisition Corp does not have any significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify and complete a business combination in the technology sector in India.
Further Reading
- Get a free copy of the StockNews.com research report on Cartica Acquisition (CITE)
- Is There a Cure for What is Ailing Teladoc Stock?
- No One Told These 3 Stocks It's a Down Week
- Why Medical Products Maker Repligen May Be A Potential Buy
- At 10%, Is Arbor Realty Trust Dividend Worth It?
- Investors Should Tune Into RF Industries
Receive News & Ratings for Cartica Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cartica Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.